Targeting SARS-CoV2 Spike Protein Receptor Binding Domain by Therapeutic Antibodies

As the number of people infected with the newly identified 2019 novel coronavirus (SARS-CoV2) is continuously increasing every day, development of potential therapeutic platforms is vital. Based on the comparatively high similarity of receptor-binding domain (RBD) in SARS-CoV2 and SARS-CoV, it seems...

Descripción completa

Detalles Bibliográficos
Autores principales: Hussain, Arif, Hasan, Anwarul, Nejadi Babadaei, Mohammad Mahdi, Bloukh, Samir Haj, Chowdhury, Muhammad E.H., Sharifi, Majid, Haghighat, Setareh, Falahati, Mojtaba
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Masson SAS. 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7395593/
https://www.ncbi.nlm.nih.gov/pubmed/32768882
http://dx.doi.org/10.1016/j.biopha.2020.110559

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7395593/
https://www.ncbi.nlm.nih.gov/pubmed/32768882
http://dx.doi.org/10.1016/j.biopha.2020.110559

Ejemplares similares